Search Results - "GREGOIRE, Marc"

Refine Results
  1. 1

    Hybrid Azo-fluorophore Organic Nanoparticles as Emissive Turn-on Probes for Cellular Endocytosis by Boucard, Joanna, Briolay, Tina, Blondy, Thibaut, Boujtita, Mohammed, Nedellec, Steven, Hulin, Philippe, Grégoire, Marc, Blanquart, Christophe, Ishow, Eléna

    Published in ACS applied materials & interfaces (11-09-2019)
    “…The development of fluorescent organic nanoparticles, serving as bioimaging agents or drug cargos, represents a buoyant field of investigations. Nevertheless,…”
    Get full text
    Journal Article
  2. 2

    Assessment of new HDAC inhibitors for immunotherapy of malignant pleural mesothelioma by Bensaid, Douae, Blondy, Thibaut, Deshayes, Sophie, Dehame, Virginie, Bertrand, Philippe, Grégoire, Marc, Errami, Mohammed, Blanquart, Christophe

    Published in Clinical epigenetics (18-06-2018)
    “…Malignant pleural mesothelioma (MPM) is a very rare and highly aggressive cancer of the pleura associated in most cases with asbestos exposure. To date, no…”
    Get full text
    Journal Article
  3. 3

    Inkjet-printed P(VDF-TrFE) film for high-frequency annular array by Banquart, Aline, Calle, Samuel, Gregoire, Jean-Marc, Ossant, Frederic, Fritsch, Lionel, Capri, Arnaud, Inglese, Jean-Marc, Chevalliot, Stephanie, Levassort, Franck

    “…An innovative processing to deposit P(VDF-TrFE) film on silicon wafers by an inkjet printing method was used to fabricate high-frequency annular array…”
    Get full text
    Journal Article
  4. 4
  5. 5

    What's the place of immunotherapy in malignant mesothelioma treatments? by Grégoire, Marc

    Published in Cell adhesion & migration (01-01-2010)
    “…Malignant pleural mesothelioma (MPM) is a rare malignancy of the pleura with a very poor prognosis. Treatments evaluated for malignant mesothelioma, including…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Measles Virus Vaccine―Infected Tumor Cells Induce Tumor Antigen Cross-Presentation by Human Plasmacytoid Dendritic Cells by GUILLERME, Jean-Baptiste, BOISGERAULT, Nicolas, ROULOIS, David, MENAGER, Jérémie, COMBREDET, Chantal, TANGY, Frédéric, FONTENEAU, Jean-François, GREGOIRE, Marc

    Published in Clinical cancer research (01-03-2013)
    “…Plasmacytoid dendritic cells (pDC) are antigen-presenting cells specialized in antiviral response. The measles virus vaccine is proposed as an antitumor agent…”
    Get full text
    Journal Article
  8. 8

    Soluble Mesothelin-related Peptides in the Diagnosis of Malignant Pleural Mesothelioma by Scherpereel, Arnaud, Grigoriu, Bogdan, Conti, Massimo, Gey, Thomas, Gregoire, Marc, Copin, Marie-Christine, Devos, Patrick, Chahine, Bachar, Porte, Henri, Lassalle, Philippe

    “…Diagnosis of malignant pleural mesothelioma is a challenging issue. Potential markers in mesothelioma diagnosis include soluble mesothelin-related peptides…”
    Get full text
    Journal Article
  9. 9

    Evaluation of intracavitary administration of curcumin for the treatment of sarcomatoid mesothelioma by Pouliquen, Daniel L, Nawrocki-Raby, Béatrice, Nader, Joëlle, Blandin, Stéphanie, Robard, Myriam, Birembaut, Philippe, Grégoire, Marc

    Published in Oncotarget (22-08-2017)
    “…A rat model of sarcomatoid mesothelioma, mimicking some of the worst clinical conditions encountered, was established to evaluate the therapeutic potential of…”
    Get full text
    Journal Article
  10. 10

    Impact of the hypomethylating agent 5-azacytidine on dendritic cells function by Frikeche, Jihane, Clavert, Aline, Delaunay, Jacques, Brissot, Eolia, Grégoire, Marc, Gaugler, Béatrice, Mohty, Mohamad

    Published in Experimental hematology (01-11-2011)
    “…Recent evidence suggested that 5-azacytidine (5-aza) can impact important immune functions via epigenetic modifications, making it an attractive candidate for…”
    Get full text
    Journal Article
  11. 11

    Impact of HDAC inhibitors on dendritic cell functions by Frikeche, Jihane, Peric, Zinaida, Brissot, Eolia, Grégoire, Marc, Gaugler, Béatrice, Mohty, Mohamad

    Published in Experimental hematology (01-10-2012)
    “…Histone deacetylase inhibitors are presently used in the routine clinic treatment against cancers. Recent data have established that some of these treatments…”
    Get full text
    Journal Article
  12. 12

    A Functional Assay to Determine the Capacity of Oncolytic Viruses to Induce Immunogenic Tumor Cell Death by Delaunay, Tiphaine, Achard, Carole, Grégoire, Marc, Tangy, Frédéric, Boisgerault, Nicolas, Fonteneau, Jean-François

    “…Oncolytic immunotherapy efficacy relies partially on the induction of immunogenic tumor cell death following infection with oncolytic viruses (OV) to induce an…”
    Get more information
    Journal Article
  13. 13

    MUC1-Specific Cytotoxic T Lymphocytes in Cancer Therapy: Induction and Challenge by Roulois, David, Fonteneau, Jean-François, Grégoire, Marc

    Published in BioMed research international (01-01-2013)
    “…MUC1 glycoprotein is often found overexpressed and hypoglycosylated in tumor cells from numerous cancer types. Since its discovery MUC1 has been an attractive…”
    Get full text
    Journal Article
  14. 14

    Identification of Novel Markers for the Diagnosis of Malignant Pleural Mesothelioma by Gueugnon, Fabien, Leclercq, Sabrina, Blanquart, Christophe, Sagan, Christine, Cellerin, Laurent, Padieu, Martine, Perigaud, Christian, Scherpereel, Arnaud, Gregoire, Marc

    Published in The American journal of pathology (01-03-2011)
    “…The diagnosis of malignant pleural mesothelioma is difficult, with the most common differential diagnoses being benign pleural diseases and metastatic…”
    Get full text
    Journal Article
  15. 15

    Targeting cell-bound MUC1 on myelomonocytic, monocytic leukemias and phenotypically defined leukemic stem cells with anti-SEA module antibodies by Guillaume, Thierry, Dehame, Virginie, Chevallier, Patrice, Peterlin, Pierre, Garnier, Alice, Grégoire, Marc, Pichinuk, Edward, Rubinstein, Daniel B., Wreschner, Daniel H.

    Published in Experimental hematology (01-02-2019)
    “…Cell surface molecules aberrantly expressed or overexpressed by myeloid leukemic cells represent potential disease-specific therapeutic targets for antibodies…”
    Get full text
    Journal Article
  16. 16

    Measles virus induces oncolysis of mesothelioma cells and allows dendritic cells to cross-prime tumor-specific CD8 response by Gauvrit, Anne, Brandler, Samantha, Sapede-Peroz, Carole, Boisgerault, Nicolas, Tangy, Frédéric, Gregoire, Marc

    Published in Cancer research (Chicago, Ill.) (15-06-2008)
    “…Despite conventional medical and surgical treatments, malignant pleural mesothelioma (MPM) remains incurable. Oncovirotherapy (i.e., the use of…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Impact of valproic acid on dendritic cells function by Frikeche, Jihane, Simon, Thomas, Brissot, Eolia, Grégoire, Marc, Gaugler, Béatrice, Mohty, Mohamad

    Published in Immunobiology (1979) (01-07-2012)
    “…Abstract Objective Recent data suggested that histone deacetylase (HDAC) inhibitors possessed potent anti-inflammatory and immunomodulatory properties both in…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Cross-Species Proteomics Identifies CAPG and SBP1 as Crucial Invasiveness Biomarkers in Rat and Human Malignant Mesothelioma by Nader, Joëlle S., Boissard, Alice, Henry, Cécile, Valo, Isabelle, Verrièle, Véronique, Grégoire, Marc, Coqueret, Olivier, Guette, Catherine, Pouliquen, Daniel L.

    Published in Cancers (01-09-2020)
    “…Malignant mesothelioma (MM) still represents a devastating disease that is often detected too late, while the current effect of therapies on patient outcomes…”
    Get full text
    Journal Article